no mention of the $70/share for the other $5 million???
In other news, the company clarified that the transactions executed with the
private investment firm that were announced last week involved restricted common
stock issued directly from the company that have a minimum hold time of 1 year
before being eligible for resale on a public market. In total, 2 agreements were
executed January 17, 2013 with the entity. The first was for a purchase of $5
million dollars worth of restricted shares at market rate at the time, which
was $70 per share, amounting to 71,428 shares. The second transaction was for
a total of 100,000 shares at $1,000,000. The average share price for the 2
transactions was $35 per share for restricted common stock. The transactions
are not contingent on any criteria to be performed by Medbox.
www.reuters.com/article/2013/02/25/ca-medbox-huffington-idUSnPnLA65453+160+PRN20130225
Medbox Featured in Huffington Post Report on the Legal Marijuana Industry
* Reuters is not responsible for the content in this press release.
Market Data 
Markets 
AI
